NASDAQ:DMRA | Income Statement | Damora Therapeutics, Inc.

Complete source-backed income-statement history.

Available history
2019-09-30 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$25.54M$34.99M-$34.99M$4.08M-$30.92M$255,000.00-$31.17M-$0.39-$0.3961,117,05761,117,057
2026-03-31$23.78M$30.81M-$30.81M$3.07M-$27.74M$42,000.00-$27.78M-$0.62-$0.6234,299,18234,299,182
2025-12-31$23.32M$201.7M-$201.7M$1M-$200.69M$44,000.00-$200.74M$10.86$10.8639,11939,119
2025-09-30$1.42M$3.16M-$3.16M$23,000.00-$3.13M$0.00-$3.13M-$2.36-$2.361,327,0391,327,039
2025-06-30$1.47M$3.42M-$3.42M-$12,000.00-$3.43M$4,000.00-$3.44M-$2.60-$2.601,322,5531,322,553
2025-03-31$678,000.00$2.6M-$2.6M$68,000.00-$2.53M$2,000.00-$2.53M-$1.92-$1.921,322,0111,322,011
2024-12-31$1.01M$7.1M-$7.1M$353,000.00-$6.75M-$8,000.00-$6.74M-$5.23-$5.2352,30052,300
2024-09-30$1.09M$3.84M-$3.84M-$36,000.00-$3.88M$7,000.00-$3.88M-$3.39-$3.391,144,9781,144,978
2024-06-30$1.83M$5.58M-$5.58M$281,000.00-$5.3M$42,000.00-$5.34M-$4.92-$4.921,084,6221,084,622
2024-03-31$2.46M$5.74M-$5.74M$264,000.00-$5.48M-$5.48M-$5.05-$5.051,084,5091,084,509
2023-12-31$2.77M$6.67M-$6.67M$196,000.00-$6.48M-$6.48M-$5.89-$5.897,1947,194
2023-09-30$2.55M$8.58M-$8.58M$447,000.00-$8.14M-$8.14M-$7.50-$7.501,084,1911,084,191
2023-06-30$8.09M$11.16M-$11.16M$415,000.00-$10.74M-$10.74M-$0.41-$0.4126,375,07626,375,076
2023-03-31$10.36M$13.49M-$13.49M$498,000.00-$12.99M-$0.51-$0.5125,672,90225,672,902
2022-12-31$10.77M$13.53M-$13.53M-$544,000.00-$14.07M-$0.55-$0.5566,97066,970
2022-09-30$10.49M$13.62M-$13.62M-$108,000.00-$13.73M-$0.54-$0.5425,491,78625,491,786
2022-06-30$13.71M$17.12M-$17.12M$234,000.00-$16.89M-$0.67-$0.6725,270,31425,270,314
2022-03-31$13.24M$16.94M-$16.94M$1,000.00-$16.94M-$0.67-$0.6725,261,83225,261,832
2021-12-31$10.12M$13.47M-$13.47M$59,000.00-$13.41M-$0.53-$0.5300
2021-09-30$9.75M$12.94M-$12.94M$243,000.00-$12.7M-$0.50-$0.5025,261,83225,261,832
2021-06-30$8.64M$12.27M-$12.27M-$34,000.00-$12.3M25,261,832
2021-03-31$9.99M$13.55M-$13.55M$207,000.00-$13.35M25,261,832
2020-12-31$7.75M$11.3M-$11.3M-$275,000.00-$11.58M4,312,736
2020-09-30$7.65M$10.17M-$10.17M-$1.49M-$11.65M259,966
2020-06-30$4.52M$6.34M-$6.34M$403,000.00-$5.94M259,966
2020-03-31$4.71M$5.83M-$5.83M$156,000.00-$5.67M259,966
2019-12-31$7.85M$24.85M$24.85M$431,000.00-$24.42M0
2019-09-30$3.67M$4.83M$4.83M$721,000.00-$4.11M259,966

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$26.88M$210.87M-$210.87M$1.08M-$209.79M$50,000.00-$209.84M$3.98$3.981,363,0051,363,005
2024-12-31$6.4M$22.26M-$22.26M$862,000.00-$21.4M$41,000.00-$21.44M-$18.53-$18.531,157,1491,157,149
2023-12-31$23.77M$39.91M-$39.91M$1.56M-$38.35M$0.00-$38.35M-$36.08-$36.081,062,8731,062,873
2022-12-31$48.21M$61.21M-$61.21M-$417,000.00-$61.62M$0.00-$61.62M-$2.43-$2.4325,409,12325,409,123
2021-12-31$38.49M$52.23M-$52.23M$475,000.00-$51.75M$0.00-$51.75M-$2.05-$2.0525,261,83225,261,832
2020-12-31$24.63M$33.64M-$33.64M-$1.2M-$34.84M$0.00-$34.84M4,572,702
2019-12-31$19.74M$38.97M$38.97M$2.46M-$36.51M$0.00-$36.51M259,966